KODATEF tafenoquine succinate

It is important that you only take this medicine on your doctor’s advice. Please contact your doctor or Healthcare Professional if you have any questions about this medicine or its use. Biocelect does not provide medical advice to patients or consumers. You will find information about your medicine in the Consumer Medicine Information below.

Kodatef is approved for malaria prevention (prophylaxis) when travelling to areas where malaria is present

Kodatef is an antimalarial indicated for the prevention of malaria in adults 18 years of age and above for up to 6 months of continuous dosing.


Copies of the Product Information and Consumer Medicine Information are available below.

* Current TGA approved indication in Australia. Kodatef is currently TGA approved in Australia. Kodatef is not approved by MedSafe in New Zealand.


New Zealand

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Australian Office: Suite 502, 139 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,

sea and community. We pay our respects to the Elders, past and present. 

Privacy Policy

  • LinkedIn Social Icon